Sunflower
SZSE · 300111
Market Cap$4.2B
Revenue$253.9M
Employees303
Listed OnSZSE
Ticker300111
CEO / ExecMr. Huaxin Shi
HeadquartersShaoxing
MarketMainland China
Websitewww.sunowe.com
Overview
Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pneumonia, and urethritis and cervicitis; and azithromycin dispersible tablets and injections for sinusi
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.